Orbitofrontal involvement in a neuroCOVID-19 patient.
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
20
05
2020
revised:
15
06
2020
accepted:
23
06
2020
pubmed:
27
6
2020
medline:
19
12
2020
entrez:
27
6
2020
Statut:
ppublish
Résumé
Neurological manifestations of coronavirus disease 19 (COVID-19) such as encephalitis and seizures have been reported increasingly, but our understanding of COVID-19-related brain injury is still limited. Herein we describe prefrontal involvement in a patient with COVID-19 who presented prior anosmia, raising the question of a potential trans-olfactory bulb brain invasion.
Identifiants
pubmed: 32589794
doi: 10.1111/epi.16612
pmc: PMC7361605
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e90-e94Informations de copyright
© 2020 International League Against Epilepsy.
Références
Epilepsia Open. 2020 May 17;5(2):314-324
pubmed: 32537529
Radiology. 2020 Aug;296(2):E119-E120
pubmed: 32228363
J Virol. 2008 Aug;82(15):7264-75
pubmed: 18495771
N Engl J Med. 2020 Jun 18;382(25):2478-2480
pubmed: 32302081
Cureus. 2020 Mar 21;12(3):e7352
pubmed: 32328364
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
Ann Intern Med. 2020 Aug 18;173(4):268-277
pubmed: 32374815
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Int J Infect Dis. 2020 May;94:55-58
pubmed: 32251791
Neurology. 2007 Apr 17;68(16 Suppl 2):S7-12
pubmed: 17438241
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Neurotherapeutics. 2020 Apr;17(2):392-403
pubmed: 32378026
Intensive Care Med. 2008 Mar;34(3):528-32
pubmed: 17992509
Travel Med Infect Dis. 2020 Jul - Aug;36:101642
pubmed: 32220634
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
Acad Radiol. 2020 Jul;27(7):1042-1043
pubmed: 32386948
Epilepsia. 2020 Aug;61(8):e90-e94
pubmed: 32589794